首页> 美国卫生研究院文献>British Journal of Clinical Pharmacology >A review of medication incidents reported to the National Reporting and Learning System in England and Wales over 6 years (2005–2010)
【2h】

A review of medication incidents reported to the National Reporting and Learning System in England and Wales over 6 years (2005–2010)

机译:回顾过去6年(2005-2010年)向英格兰和威尔士国家报告和学习系统报告的用药事件

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

A review of all medication incidents reported to the National Reporting and Learning System (NRLS) in England in Wales between 1 January 2005 and 31 December 2010 was undertaken. The 526 186 medication incident reports represented 9.68% of all patient safety incidents. Medication incidents from acute general hospitals (394 951) represented 75% of reports. There were relatively smaller numbers of medication incident reports (44 952) from primary care, representing 8.5% of the total. Of 86 821 (16%) medication incidents reporting actual patient harm, 822 (0.9%) resulted in death or severe harm. The incidents involving medicine administration (263 228; 50%) and prescribing (97 097; 18%) were the process steps with the largest number of reports. Omitted and delayed medicine (82 028; 16%) and wrong dose (80 170; 15%) represented the largest error categories. Thirteen medicines or therapeutic groups accounted for 377 (46%) of the incidents with outcomes of death or severe harm. The National Patient Safety Agency (NPSA) has issued guidance to help minimize incidents with many of these medicines. Many recent incidents could have been prevented if the NPSA guidance had been better implemented. It is recommended that healthcare organizations in all sectors establish an effective infrastructure to oversee and promote safe medication practice, including an annual medication safety report. In the future, preventable harms from medication incidents can be further minimized by; the continued use of the NRLS to identify and prioritize important actions to improve medication safety, a central organization continuing to issue medication safety guidance to the service and better methods to ensure that the National Health Service has implemented this guidance.
机译:对2005年1月1日至2010年12月31日期间向威尔士英格兰国家报告与学习系统(NRLS)报告的所有用药事件进行了审查。 526186起药物事件报告占所有患者安全事件的9.68%。急性综合医院的药物事件(394 951)占报告的75%。来自初级保健的药物事件报告相对较少(44 952),占总数的8.5%。在86 821起(16%)药物事件中,报告实际造成患者伤害的事件中,有822(0.9%)次导致死亡或严重伤害。涉及药物管理(263 228; 50%)和处方(97 097; 18%)的事件是报告数量最多的过程步骤。误差最大的类别为遗漏和延误药物(82 028; 16%)和错误剂量(80 170; 15%)。 13种药物或治疗组占死亡或严重伤害结果的377起(46%)。国家患者安全局(NPSA)已发布指南,以帮助最大程度地减少许多此类药物的事故发生。如果能够更好地执行NPSA指南,则可以避免许多最近发生的事件。建议所有部门的医疗机构都建立有效的基础设施,以监督和促进安全用药实践,包括年度用药安全报告。将来,可以通过以下方法进一步减少药物事件可预防的危害:继续使用NRLS来识别和优先考虑改善药物安全性的重要行动,中央组织继续向服务部门发布药物安全性指南,并采用更好的方法来确保National Health Service已实施该指南。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号